Mauro Capocci
Sapienza University of Rome
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mauro Capocci.
Clinica Terapeutica | 2017
Umberto Romeo; Livia Ottolenghi; Fabrizio Guerra; Alice Mannocci; Susanna Annibali; Mauro Capocci
BACKGROUNDnMRONJ (medication related osteonecrosis of the jaws) is a well-known side effect of certain drugs, which are used to influence bone metabolism for the cure of osteo-metabolic or cancer diseases. The aim of this study is to assess the quality of life (QOL) under a physical and mental point of view in patients affected by MRONJ compared with the general population.nnnMETHODSnThe study has been accomplished through the administration of the SF-12 questionnaire: 30 patients of the MRONJ group were evaluated.nnnRESULTSnSignificant differences based on the level of education and age of the subjects, on the location and finally on the stage of necrosis of the jaw have been identified. In this pilot study the test sample shows how MRONJ can aggravate the conditions of patients, above all under a physical point of view.nnnCONCLUSIONSnPrevention of MRONJ and its symptoms as dysphagia, oral pain, immunological compromission and the need of frequent antibiotic therapies is a crucial part of modern oral pathology and dentistry, above all for oncologic patients who already have a general decrease of physical and mental activities, leading to a poor quality of life.
International Journal of Dentistry | 2014
Mauro Capocci; Umberto Romeo; Fabio Cocco; Isabella Bignozzi; Susanna Annibali; Livia Ottolenghi
Aim. To describe 7 years of activity of “CROMa” (Coordination of Research on Osteonecrosis of the Jaws) project of “Sapienza” University of Rome. Materials and Methods. A preventive and therapeutic care pathway was created for patients with bisphosphonates (BPs) exposure. Demographic, social, behavioural, pharmacological, and clinical variables were registered in a dedicated database. Results. In the project, 502 patients, 403 females and 99 males, were observed. Bone pathologies were 79% osteometabolic diseases (OMD) and 21% metastatic cancer (CA). Females were 90% in OMD group and 41% in CA. BP administration was 54% oral, 31% IV, and 11% IM; 89% of BPs were amino-BP and 11% non-amino-BP. Consistently with bone pathology (OMD/CA), alendronate appears to be prevalent for OMD (40% relative), while zoledronate was indicated in 92% of CA patients. Out of 502 cases collected, 28 BRONJ were detected: 17 of them were related to IV BP treatment. Preventive oral assessment was required for 50% of CA patients and by 4% of OMD patients. Conclusions. The proposed care pathway protocols for BP exposed patients appeared to be useful to meet treatment and preventive needs, in both oncological and osteometabolic diseases patients. Patients and physicians prevention awareness can be the starting point of a multilevel prevention system.
The British Journal for the History of Science | 2011
Daniele Cozzoli; Mauro Capocci
This paper focuses on the role played by Domenico Marotta, director of the ISS (Higher Institute of Health) for over twenty-five years, in the development of twentieth-century Italian biomedicine. We will show that Marotta aimed to create an integrated centre for research and production able to interact with private industry. To accomplish this, Marotta shifted the original mission of the ISS, from public health to scientific research. Yet Mussolinis policy turned most of the ISS resources towards controls and military tasks, opposing Marottas aspiration. By contrast, in the post-war years Marotta was able to turn the ISS into the most important Italian biomedical research institution, where research and production fruitfully cohabited. Nobel laureates, such as Ernst Chain, and future Nobel laureates, such as Daniel Bovet, were hired. The ISS built up an integrated research and production centre for penicillin and antibiotics. In the 1960s, Marottas vision was in accord with the new centre-left government. However, he pursued his goals by ruling the ISS autocratically and beyond any legal control. This eventually led to his downfall and prosecution. This also marked the decline of the ISS, intertwined with the weakness of the centre-left government, who failed to achieve structural reforms and couple the modernization of the country with the democratization of its scientific institutions.
5th Congress of the World Federation for Laser Dentistry and 6th International Conference on Lasers in Medicine: High-End Medicine Based on Laser and Biotechnologies | 2016
Mauro Capocci; Mohamed Mohsen; R. Lo Giudice; A. Del Vecchio; Gianfranco Gaimari; L. Tribolati; Gaspare Palaia; Umberto Romeo
Oral leukoplakia is catalogued under the group of “potentially malignant disorders”. In daily practice, the World Health Organization definition “white patch or plaque that cannot be characterized clinically or histologically as any other disease” is completed by including the observation that it cannot be removed by simple scraping, thereby distinguishing it from pseudo-membranous candidiasis. The aim of this study is to find a definitive treatment of oral leukoplakia, because of its recurrence and its potentiality to the malignant transformation. There are currently different approaches to oral leukoplakia: scalpel surgery, systemic therapy (carotenoids, vitamins, etc.), electro-cauterization, cryotherapy and the use of the laser. In every lesion, biopsy and histological analysis has been performed to identify the stage and classification of the oral leukoplakia. Laser can be used for the complete excision of the lesion (which is more effective, but also more invasive), for the photodynamic therapy (non-invasive procedure, which requires several applications) or for the vaporization of the lesion (very precise treatment and relatively easy to perform). Laser treatments have shown better healing, less soft tissues retraction and less post-operative pain, comparing with traditional surgery. The use of systemic therapies and smoking habit interruption (where present) has been also useful to reduce the lesions before the clinical treatments. The treatment has always to be supported by histological analysis to identify the risk and consequently planning the clinical approach.
Cell Stress & Chaperones | 2014
Mauro Capocci; M. Gabriella Santoro; Lawrence E. Hightower
Ferruccio Ritossa wrote these lines only a few months before he died, as a preface to a book he wanted to write and that, unfortunately, we will never be able to read. It was to be the story of his life, an amazing story indeed. With this article, we want to take a picture of Ferruccio’s life, a mosaic of events, facts, ideas, hopes, and memories linked in a way that they will not go away, even after “a stroll in our brain.”
Medicina nei secoli | 2014
Mauro Capocci
Medicina nei secoli | 2006
Mauro Capocci
The British Journal for the History of Science | 2018
Mauro Capocci
Clinica Terapeutica | 2018
Gianna Maria Nardi; Marta Mazur; Denise Corridore; Mauro Capocci; F. Md. Rinaldo; Antonello Maruotti; Livia Ottolenghi
Medicina nei secoli | 2017
Mauro Capocci